Other Species / Isoforms
  MOCS2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S12
EISSSCFSLEtKLPL
0 1
MOCS2 (human) EISSSCFSLEtKLPL S12
MOCS2 iso2 (human) gap -
MOCS2 (mouse) EISNSCFsPETRSPS S12-p
T15-p
SSCFSLEtKLPLsPP
0 1
MOCS2 (human) SSCFSLEtKLPLsPP T15-p
MOCS2 iso2 (human) gap -
MOCS2 (mouse) NSCFsPETRSPSSRQ T15
S20-p
LEtKLPLsPPLVEDS
Upstream
0 23
Treatment
  • anti-CD3
  • LRRK2-IN-1
  • metastatic potential
  • nocodazole
MOCS2 (human) LEtKLPLsPPLVEDS S20-p
MOCS2 iso2 (human) gap -
MOCS2 (mouse) PETRSPSSRQsVEDN S20
L23
KLPLsPPLVEDSAFE
0 1
MOCS2 (human) KLPLsPPLVEDSAFE L23
MOCS2 iso2 (human) gap -
MOCS2 (mouse) RSPSSRQsVEDNASE S23-p
K42
DMDEVEEKSKDVINF
0 1
MOCS2 (human) DMDEVEEKSKDVINF K42
MOCS2 iso2 (human) gap -
MOCS2 (mouse) DVDDVQEkPKDIIQF K42-ub
Y170-p
PIWKKEIyEESSTWK
0 1
MOCS2 (human) PIWKKEIyEESSTWK Y170-p
MOCS2 iso2 (human) gap -
MOCS2 (mouse) PIWKKEIYEESTSSW Y170
S188-p
ECFWASNs_______
0 3
MOCS2 (human) ECFWASNs_______ S188-p
MOCS2 iso2 (human) gap -
MOCS2 (mouse) ECFWAAGD_______ D189
-
gap
0 1
MOCS2 (human) gap -
MOCS2 iso2 (human) EVLYFAKsAEITGVR S15-p
MOCS2 (mouse) gap -
-
gap
0 1
MOCS2 (human) gap -
MOCS2 iso2 (human) ITGVRSEtISVPQEI T25-p
MOCS2 (mouse) gap -
-
gap
0 3
MOCS2 (human) gap -
MOCS2 iso2 (human) IKALQLWkEIETRHP K39-ub
MOCS2 (mouse) gap -